Frontier Capital Management Co Llc
Source: SEC Form 13F · as of Mar 2026Frontier Capital Management Co Llc holds 11 biotech & pharma companies tracked by BioSniper, totaling $502.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$502.5M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Jazz Pharmaceuticals plc (JAZZ)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| JAZZJazz Pharmaceuticals plc | 517,284 | $97.8M |
| APGEApogee Therapeutics, Inc. | 1,064,483 | $89.6M |
| INSMINSMED Inc | 469,561 | $76.8M |
| BBIOBridgeBio Pharma, Inc. | 957,989 | $71.1M |
| PVLAPALVELLA THERAPEUTICS, INC. | 374,035 | $46.6M |
| NUVLNuvalent, Inc. | 395,546 | $40.5M |
| AXSMAxsome Therapeutics, Inc. | 203,066 | $34.3M |
| RVMDREVOLUTION MEDICINES, INC. | 243,804 | $23.7M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 30,604 | $10.1M |
| VCELVericel Corp | 273,725 | $8.8M |
| VRDNViridian Therapeutics, Inc.\DE | 158,371 | $3.1M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.